Intensive BP control and incident kidney disease: what can we learn from urinary biomarkers?

Affiliations

¹ Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: alp.ikizler@vanderbilt.edu.
² Division of Nephrology, Department of Medicine, Colombia University, New York, New York, USA.
³ Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.

Free article

Comment

T Alp Ikizler et al. Kidney Int. 2019 May.

Free article

. 2019 May;95(5):1007-1009.

doi: 10.1016/j.kint.2019.02.004. Epub 2019 Mar 7.

¹ Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: alp.ikizler@vanderbilt.edu.
² Division of Nephrology, Department of Medicine, Colombia University, New York, New York, USA.
³ Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.

No abstract available

Keywords: biomarkers; cardiovascular disease; chronic kidney disease.

Comment on

Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
Zhang WR, Craven TE, Malhotra R, Cheung AK, Chonchol M, Drawz P, Sarnak MJ, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group. Zhang WR, et al. Ann Intern Med. 2018 Nov 6;169(9):610-618. doi: 10.7326/M18-1037. Epub 2018 Oct 23. Ann Intern Med. 2018. PMID: 30357395 Free PMC article. Clinical Trial.